Author: Piers Townley

This promising technique was developed by Researchers from the University of Oxford, UK and the University of Twente, Netherlands

Yesterday, Macmillan Wales and the Welsh Government published the second Wales Cancer Patient Experience Survey

The annual report by Prof Dame Sally Davies says that the genomic plan should be implemented within 5 years in the NHS

HeadSmart is a finalist in the National Lottery Awards ‘Best Health Project’ category

A probe that was first developed by researchers in Canada in 2015 has since been perfected by the team

A groundbreaking international centre for research into childhood brain tumours will be launched today (June 27) in London

A new study from the CSIR-Institute of Genomics and Integrative Biology in India examined the mechanism of gene expression within brain tumours and found a lack of microRNA editing

Scientists from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the protein BCL6 could potentially be used as a marker to predict the clinical outcome of patients with glioblastoma

After seven weeks of relentless political campaigning across the UK, voters finally had their say at polling booths on Thursday, as a shock ‘hung parliament’ result emerged

A study conducted by Judith Schwartzbaum from the University of Ohio has found that changes in the immune systems appear to signal brain cancer 5 years before symptoms arise

Researchers from the University of Texas MD Anderson have discovered an enzyme that helps brain tumours grow in nutrient-starved environments

Yesterday saw the launch of the Less Survivable Cancers Taskforce to an audience of members of the Scottish Parliament in Holyrood, Edinburgh

The University of Cambridge is to begins trials using the Zika virus on glioblastoma, the most common and aggressive form of brain tumour. Glioblastomas affect 2,200 people in the UK each year

The terminal illness charity is looking for applications that address its key research priorities identified by carers, health and social care professionals and people with terminal illness, and particularly, those areas that have until now received the least attention

Researchers from the Nottingham University’s children’s brain tumour centre are now looking into the effects of cannabidiol (CBD), the non-psychoactive ingredient in marijuana

The Brain Tumour Charity CEO, Sarah Lindsell, has co-signed a letter to NHS organisations urging them to meet their one-year survival targets for the early diagnosis of brain tumours.

Trainee neurosurgeon at University Hospital Coventry and Warwickshire, Yasir Chowdhury, shines a light on day-to-day life in one of the most complex and dangerous areas of surgery and shares his hopes for finding a cure for brain tumours

Last week Bristol-Myers Squibb announced the initial results from their Phase 3 clinical trial that was assessing the effectiveness and safety of the immunotherapy drug Nivolumab in patients with recurrent glioblastoma.

BrainPath is a surgical technique that uses the brain’s own tissue folds to tract a path to the tumour site. It is designed to be minimally invasive.

Researchers at McGill University Health Centre (MUHC), Montreal have developed a new clinical approach to enhance the efficiency of treatment for glioblastomas, which increased the average survival time to 22 months.

The Imaging Centre of Excellence (ICE), was opened last Wednesday at the University of Glasgow, with the aim to be a global hub for precision medicine.

Researchers at St. Jude Children’s Research Hospital, USA have revealed how a key protein involved in driving the growth of the most aggressive form of medulloblastoma also plays a role in stopping its development.

Scientists from The Institute of Cancer Research (ICR) have discovered 13 new genetic errors related with an increased risk of developing glioma in one of the largest ever studies of this devastating disease

Construction on the building of one of the UK’s first Proton Beam Therapy (PBT) facilities is well under way at University College London Hospital.